Ethyl 8-oxo-1,4,5,6,7,8-hexahydrocyclohepta[b]pyrrole-2-carboxylate

Catalog No.: 
ACLENQ734
CAS No.: 
1979149-35-3
Molecular Formula: 
C12H15NO3
Molecular Weight: 
221.26
Ethyl 8-oxo-1,4,5,6,7,8-hexahydrocyclohepta[b]pyrrole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$211.00InquiryInquiry
250mg98%$416.00InquiryInquiry
1g98%$752.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 8-oxo-1,4,5,6,7,8-hexahydrocyclohepta[b]pyrrole-2-carboxylate
IUPAC Nameethyl 8-oxo-1,4,5,6,7,8-hexahydrocyclohepta[b]pyrrole-2-carboxylate
MDL No.MFCD31811613
Molecular FormulaC12H15NO3
Molecular Weight221.26
SMILESO=C(C1=CC(CCCCC2=O)=C2N1)OCC
InChI KeyPPHLXUGBYPBUDO-UHFFFAOYSA-N
SynonymEthyl 8-Oxo-1,4,5,6,7,8-hexahydrocyclohepta[b]pyrrole-2-carboxylate;Cyclohepta[b]pyrrole-2-carboxylic acid, 1,4,5,6,7,8-hexahydro-8-oxo-, ethyl ester;ethyl 8-oxo-4,5,6,7-tetrahydro-1H-cyclohepta[b]pyrrole-2-carboxylate
CAS No.1979149-35-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLENQ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLENQ734 route product structure diagram
    ACLENQ7341979149-35-3
Inquiry

2. ACLENQ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLENQ734 route product structure diagram
    ACLENQ7341979149-35-3
Inquiry

3. ACLENQ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLENQ734 route product structure diagram
    ACLENQ7341979149-35-3
Inquiry

Comments (0)